Abstract: A dental care product, in particular a toothpaste, containing calcium phosphate compounds is free of fluorine compounds and free of silicon compounds and contains at least one surfactant selected from taurates, glycinates or sarcosinates. The dental care product remineralizes smaller caries lesions and/or repairs microfine defects in the tooth enamel, in particular also in patients with dry mouth/saliva deficiency.

Abstract: An oral care agent, in particular toothpaste or mouthwash, contains a methylxanthine, selected from the group consisting of caffeine, theobromine and theophylline, and a calcium phosphate compound, preferably in particulate form, selected from the group consisting of monocalcium phosphate monohydrate (MCPM), anhydrous monocalcium phosphate (AMCP), octacalcium phosphate (OCP), amorphous calcium phosphate (ACP), calcium-deficient hydroxyapatite (CDHA), hydroxyapatite (HA or HAP) and tetracalcium phosphate (TTCP), particularly preferably hydroxyapatite. The addition of methylxanthines, of which preferably caffeine is used, in combination with the other compounds achieves a synergistic effect.

Abstract: The present invention relates to a composition which, in addition to caffeine, also contains dimethylglycine and/or a salt of dimethylglycine. In addition, the present invention relates to the use (cosmetic and/or medicinal) of this composition for the treatment of hair, scalp and/or skin.

Abstract: An oral gel composition to be applied to the gums and to remain thereon for at least 3 minutes, is used for oral care, and in particular for effective treatment of (i.e. reducing and preventing) periodontitis/gingivitis and gum recession. The oral gel composition includes at least 0.00001 and less than 0.5% by weight caffeine and a gelling agent. The oral gel composition allows cell metabolism to be activated and thus allows effective treatment and/or prevention of periodontitis/gingivitis and gum recession.

Abstract: The present invention relates to a topical composition comprising dimethylglycine and/or a salt of dimethylglycine and having a pH of 3.0 to 5.9. In addition, the present invention relates to the use (cosmetic and/or medicinal) of this composition for the treatment of hair and/or skin.

Abstract: The present invention relates to a composition containing dimethylglycine and/or a salt of dimethylglycine. In addition, the present invention relates to the use (cosmetic and/or medicinal) of this composition for the treatment of hair and scalp.

Abstract: The invention relates to a composition comprising hydroxyapatite for use in the treatment and/or prevention of a virus infection.

Abstract: The invention relates to the treatment of hair loss with minoxidil and caffeine.

Abstract: The invention relates to an oil-in-water emulsion containing 15.0 to 30.0 wt.-% ethanol.

Abstract: The present invention relates to the use of Ca5(PO4)3(OH) (hydroxyapatite; HAP) and a dental care composition comprising Ca5(PO4)3(OH) for the deep-layer remineralization of demineralized teeth, in particular for the deep-layer remineralization of demineralized dental enamel. Ca5(PO4)3(OH) used according to the invention and the dental care composition used according to the invention can be applied in the treatment and/or prevention of various diseases affecting the teeth, in particular caries.

Abstract: The present invention relates to an oil-in-water emulsion comprising a glycopyrronium salt and an emulsifier system comprising at least one macrogol glycerol fatty acid ester, at least one glycerol fatty acid ester and at least one fatty alcohol. Moreover, the present invention relates to such an emulsion for use as a medicament, in particular for treating and preventing diseases in conjunction with excessive sweating. In addition the present invention relates to the non-therapeutic use of such an oil-in-water emulsion for topical application on the skin of a mammal in order to reduce sweating.

Abstract: The present invention relates to a floor grinding apparatus (100) with a housing (110) having an interior space (111) open to one side, a carrier plate (120) rotatably mounted in the interior space (111) for receiving abrasives, and drive unit (130) adapted to rotate the carrier plate (120), the housing (110) having an inner dust sealing ring (112) with at least one recess (115), wherein the inner dust sealing ring (112) divides the interior space (111) into an inner portion (113) and an outer portion (114), and wherein the carrier plate (120) is disposed in the inner portion (114), at least one extraction opening (116) disposed in the outer portion (114), and an outer dust sealing ring (117) enclosing the interior space (111), the inner dust sealing ring (112) and the outer dust sealing ring (117) being arranged to define a common working plane parallel to the plane of rotation of the carrier plate (120).

Abstract: The present invention relates to tripeptide compounds according to the general formula (1) and their use as a medicament, in particular as anti-inflammatory agents.

Abstract: The present invention relates to a milling drum for removing glued-down floor coverings, in particular wooden floor coverings, preferably parquet floor coverings, in particular multilayer parquet, with a predetermined milling width which determines the width of a floor surface section by running the milling drum over the floor surface section to be machined, having a plurality of cutting plates which are arranged tangentially on the milling drum and which are arranged in a distributed manner on the milling drum, such that, upon a complete revolution of the milling drum, the entire milling width is operable with at least one cutting plate and such that a common width of the cutting plates being in contact simultaneously with the floor surface section to be machined is always smaller than the milling width.

Abstract: The invention relates to Lysyl-Prolyl-Threonine lyophilized formulations, in particular to L-Lysyl-D-Prolyl-L-Threonine lyophilized formulations, that are stable in storage, and to a process for preparing the lyophilized formulations. Moreover, the invention relates to pharmaceutical and cosmetic compositions comprising the lyophilized formulations, that are used in the therapeutic and/or prophylactic treatment, diagnosis and/or therapy of pain-related diseases, pruritus-related diseases, inflammatory diseases, and/or other diseases in a mammal.

Abstract: The present invention relates to a floor grinding apparatus (100) with a housing (110) having an interior space (111) open to one side, a carrier plate (120) rotatably mounted in the interior space (111) for receiving abrasives, and drive unit (130) adapted to rotate the carrier plate (120), the housing (110) having an inner dust sealing ring (112) with at least one recess (115), wherein the inner dust sealing ring (112) divides the interior space (111) into an inner portion (113) and an outer portion (114), and wherein the carrier plate (120) is disposed in the inner portion (114), at least one extraction opening (116) disposed in the outer portion (114), and an outer dust sealing ring (117) enclosing the interior space (111), the inner dust sealing ring (112) and the outer dust sealing ring (117) being arranged to define a common working plane parallel to the plane of rotation of the carrier plate (120).

Abstract: The present invention relates to tripeptide compounds according to the general formula (1) and their use as a medicament, in particular as anti-inflammatory agents.

Abstract: The use of eprotirome in the prevention and/or treatment of hair disorders is herein disclosed.

Abstract: The present invention relates to perhydroquinoxaline compounds according to the general formula (1), their use as a medicament, in particular as analgesic, antipruritic and anti-inflammatory agents, and their preparation.

Abstract: The present invention relates to a novel class of 1,3-benzoxazol-2(3H)-ones and their use as a medicament, preferably as a dermatologic agent, and as a cosmetic. These novel compounds are particularly useful in treating and/or preventing inflammation, irritation, itching, pruritus, pain, oedema and/or pro-allergic or allergic conditions in a patient. Usually they are topically applied to the skin or mucosa in the form of a pharmaceutical or cosmetic composition comprising the compound and a pharmaceutically and/or cosmetically acceptable carrier.